Borazan Ali, Comert Mustafa, Ucan Bülent Hamdi, Comert Fusun Begendik, Sert Mehmet, Sekitmez Nedred, Cesur Ali
Department of Internal Medicine, Zonguldak Karaelmas University, The School of Medicine, Zonguldak, Turkey.
Ren Fail. 2006;28(1):37-42. doi: 10.1080/08860220500461237.
Starting continuous ambulatory peritoneal dialysis (CAPD) immediately after insertion of a peritoneal dialysis catheter is essential in end-stage renal disease (ESRD). In relation to the insertion methods, various mechanical and infectious complications may arise. In this study, we aimed to compare early complications of the laparoscopic tunneling method of CAPD placement that we developed recently in order to minimize the complications, with those of the conventional percutaneous method.
Included in this study were 12 consecutive patients with ESRD to whom we introduced catheters for CAPD by way of laparoscopic tunneling between April 2003 and July 2003 and followed up for at least 6 months, and 30 patients to whom the catheters were placed percutaneously in the same time period with the same follow-up time. The complications seen during the first 6 months after catheter placement with these two different methods were compared.
In all of the subjects, dialysis was started soon after catheter placement. No peroperative morbidity was seen in any of the patients. While with laparoscopic tunneling method no mechanical problem was seen, the percutaneous method resulted in early leakage in 10%, pericatheter bleeding in 3.3%, and hernia in 3.3% of the patients. As infectious complications, peritonitis occurred as one episode/36 patient-months in laparoscopic tunneling and one episode/22.5 patient-months in percutaneous method; catheter insertion site infection was seen in none in the laparoscopic method, while one episode/90patient-months was seen with the percutaneous method. Tunnel infection did not arise in any of the subjects.
The authors of this study think that the peritoneal tunneling method for introducing CAPD, which has been recently developed and began to be routinely used by them, is rather safe in terms of early complications.
对于终末期肾病(ESRD)患者,在插入腹膜透析导管后立即开始持续非卧床腹膜透析(CAPD)至关重要。就插入方法而言,可能会出现各种机械性和感染性并发症。在本研究中,我们旨在比较我们最近开发的用于CAPD置管的腹腔镜隧道法(为尽量减少并发症)与传统经皮法的早期并发症。
本研究纳入了2003年4月至2003年7月期间通过腹腔镜隧道法为12例连续性ESRD患者插入CAPD导管并随访至少6个月的病例,以及同期采用经皮法置管且随访时间相同的30例患者。比较了这两种不同方法在导管置入后前6个月出现的并发症。
所有受试者在导管置入后不久即开始透析。所有患者均未出现术中并发症。腹腔镜隧道法未出现任何机械问题,而经皮法导致10%的患者出现早期渗漏,3.3%的患者出现导管周围出血,3.3%的患者出现疝气。作为感染性并发症,腹腔镜隧道法腹膜炎发生率为每36患者月1次发作,经皮法为每22.5患者月1次发作;腹腔镜法未出现导管插入部位感染,而经皮法为每90患者月1次发作。所有受试者均未出现隧道感染。
本研究的作者认为,他们最近开发并开始常规使用的用于引入CAPD的腹膜隧道法在早期并发症方面相当安全。